Elsevier

Clinical Nutrition

Volume 29, Issue 2, April 2010, Pages 154-159
Clinical Nutrition

Opinion Paper
Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”

https://doi.org/10.1016/j.clnu.2009.12.004Get rights and content

Summary

Chronic diseases as well as aging are frequently associated with deterioration of nutritional status, loss muscle mass and function (i.e. sarcopenia), impaired quality of life and increased risk for morbidity and mortality. Although simple and effective tools for the accurate screening, diagnosis and treatment of malnutrition have been developed during the recent years, its prevalence still remains disappointingly high and its impact on morbidity, mortality and quality of life clinically significant. Based on these premises, the Special Interest Group (SIG) on cachexia-anorexia in chronic wasting diseases was created within ESPEN with the aim of developing and spreading the knowledge on the basic and clinical aspects of cachexia and anorexia as well as of increasing the awareness of cachexia among health professionals and care givers. The definition, the assessment and the staging of cachexia, were identified as a priority by the SIG. This consensus paper reports the definition of cachexia, pre-cachexia and sarcopenia as well as the criteria for the differentiation between cachexia and other conditions associated with sarcopenia, which have been developed in cooperation with the ESPEN SIG on nutrition in geriatrics.

Introduction

The close association between chronic illnesses and the deterioration of nutritional status, impaired quality of life and increased risk for morbidity and mortality has been long recognised.1 Indeed, as early as in the third century B.C., the Greek physician Hippocrates from Koos very neatly described the wasting syndrome associated with terminal disease: “The flesh is consumed and becomes water,the abdomen fills with water, the feet and the legs swell, the shoulders, clavicles, chest and thighs melt awayThis illness is fatal”.2

The spectrum of metabolic and nutritional abnormalities secondary to chronic diseases is indeed wide and multifactorial in origin.3, 4 Consensus exists, however, that the pathogenesis of malnutrition shares analogies and bear diversities among the causative underlying conditions.5 The progressive knowledge of the negative impact of malnutrition on patients’ prognosis has led to the development of simple but effective tools which allow for the accurate screening, diagnosis and treatment of malnutrition.6, 7 This notwithstanding, the prevalence of malnutrition in hospital and the community still remains disappointingly high,1, 8 underdiagnosed and frequently left untreated until extreme pictures may develop, which are currently referred to as ‘cachexia’, ‘cachectic states’ or ‘severe wasting’. On the other hand, it is well recognized that such advanced clinical pictures are scarcely responsive to the available nutritional and pharmacological treatments,9, 10 suggesting that once a critical point is reached, the complex interplay between underlying disease, metabolic alterations and reduced availability of nutrients will eventually and ineluctably cause the patient's death. This underscores the urgent need for the development of early and effective interventions aimed at preventing rather than treating those abnormalities ultimately leading to the clinical picture of cachexia.

Based on these premises, in 2005, the Special Interest Group (SIG) on cachexia-anorexia in chronic wasting diseases was created within ESPEN. The main aims of this SIG are the development and diffusion of knowledge on the basic and clinical aspects of cachexia and anorexia. The secondary aims are to increase the awareness of cachexia among health professionals and caregivers and to develop clinical guidelines for the prevention/treatment of cachexia. This would ultimately allow to promote appropriate interventions at the institutional and political levels.

The definition, the assessment and the staging of cachexia, was identified as a priority by the SIG. The lack of a simple and commonly accepted definition for cachexia still represents a main clinical issue, leading to clinically relevant mistakes, lack or delay in identification, inadequate prevention and frequently ineffective treatments.

This consensus paper reports the definition of cachexia and pre-cachexia. Moreover, the criteria for the differentiation between cachexia and other conditions associated with sarcopenia (i.e. loss of muscle mass) are reported, which have been developed in cooperation with the ESPEN SIG on nutrition in geriatrics.

The SIG nutrition in geriatrics was created in 2006 to focus on nutritional disorders of specific relevance for the elderly. Age-related sarcopenia is a concept that describes the loss of muscle mass and muscle strength associated with aging. In its advanced stages it causes disability and dependence. In order to implement diagnostic and therapeutic strategies, a definition for this entity is urgently needed. For that purpose, the SIG joined forces with the SIG on cachexia-anorexia in chronic wasting diseases for a common ESPEN position paper.

Section snippets

How to define sarcopenia?

The term sarcopenia is derived from the Greek words sarx (flesh) and penia (poverty). Sarcopenia is a condition characterized by loss of muscle mass and muscle strength.11, 12 Muscle accounts for 60% of the body's protein stores. Muscle mass decrease is directly responsible for functional impairment with loss of strength, increased likelihood of falls, and loss of autonomy.13, 14 Respiratory function is also impaired with a reduced vital capacity.15 During a metabolic stress situation muscle

What is age-related sarcopenia?

Age-related sarcopenia is the loss of muscle mass and muscle strength that is associated with aging.11, 12 Features of sarcopenia include: decreased muscle mass and cross-sectional area, infiltration of muscle by fat and connective tissue, decrease of type 2 fiber size and number, but also of type 1 fibers, accumulation of internal nuclei, ring fibers and ragged fibers, disarrangement of myofilaments and Z-lines, proliferation of the sarcoplasmic reticulum and t-tubular system, accumulation of

How to diagnose sarcopenia?

Diagnosis of sarcopenia is based on the combined presence of the two following criteria:

I. A low muscle mass, i.e. a percentage of muscle mass ≥2 standard deviations below the mean measured in young adults of the same sex and ethnic background.

Subjects aged 18–39 years in the 3rd NHANES population13 might be used as reference. The suggested T-score-based diagnosis of sarcopenia relates closely to the diagnosis of osteoporosis. Like for osteopenia/osteoporosis, much needed reference values in

How to define cachexia?

The term cachexia is derived from the Greek words kakòs (bad) and héxis (condition). Cachexia may be defined as a multifactorial syndrome characterized by severe body weight, fat and muscle loss and increased protein catabolism due to underlying disease(s). Cachexia is clinically relevant since it increases patients’ morbidity and mortality. Contributory factors to the onset of cachexia are anorexia and metabolic alterations, i.e. increased inflammatory status, increased muscle proteolysis,

Why is the staging of cachexia necessary?

One of the innovative aspects of the present re-appraisal of cachexia in chronic diseases is the attempt to stage cachexia. The SIGs felt the staging of cachexia as necessary, based on a number of reasons that are listed below:

  • (a)

    late-stage cachexia is substantially untreatable with currently available tools42;

  • (b)

    increasing the awareness of conditions potentially leading to cachexia is mandatory;

  • (c)

    staging may facilitate identification of early markers of cachexia;

  • (d)

    there is emerging consensus that

How to define ‘pre-cachexia’?

Pre-cachexia is defined based on the presence of all the following criteria:

  • (a)

    underlying chronic disease;

  • (b)

    unintentional weight loss ≤5% of usual body weight during the last 6 months;

  • (c)

    chronic or recurrent systemic inflammatory response;

  • (d)

    anorexia or anorexia-related symptoms.

Pre-cachexia includes therefore patients with a chronic disease, small weight loss, a chronic or recurrent systemic inflammatory response and anorexia. Inflammation is indicated by elevated serum levels of inflammatory markers like

Is cachexia associated with changes in body composition?

Yes. One of the hallmark of cachexia is loss of body weight, which is brought about by loss of both lean and fat mass.47 In advanced cachexia, water retention may occur as a consequence of severe hypoalbuminemia. The water retention may then account for an increase in body weight in spite of severe body wasting.48 The same may occur in patients with severe heart failure, liver cirrhosis or renal failure, in whom loss of body weight may be obscured by fluid retention.49

Loss of skeletal muscle

Can an obese person be defined as pre-cachectic?

Within the frame of our definition of ‘pre-cachexia’, muscle wasting may be frequently observed in obese or overweight patients exhibiting unintentional weight loss and systemic inflammatory response due to underlying disease, such as cancer.61 These patients exhibit significant muscle loss despite fat mass is still increased. This condition is therefore defined as sarcopenic obesity. The current definition of obesity is anthropometric and based on body mass index and does not take into account

Is it possible to differentiate cachexia from other sarcopenic conditions?

Not always. Loss of muscle mass is a feature of cachexia, whereas most sarcopenic subjects are not cachectic. Persons with no weight loss, no anorexia, no measurable systemic inflammatory response may well be sarcopenic. Sarcopenia may be accelerated after an acute inflammatory stress, and may also involve, in the elderly, a low-grade systemic inflammatory response or insulin resistance.66, 67, 68 However, none of these inflammatory conditions match the definition of cachexia. As inflammation

Conclusion

A universally accepted definition of the clinical syndrome of cachexia would represent a major achievement in clinical medicine, allowing for early recognition, prevention and timely-appropriate treatment of this devastating condition. Cachexia has been long considered a late and ineluctable event complicating the natural history of many chronic diseases such as cancer, chronic heart failure, COPD, chronic renal failure, etc. Moreover, the negligible response of cachexia to available

Conflict of interest statement

None declared.

References (71)

  • H. Lochs et al.

    Introductory to the ESPEN guidelines on Enteral Nutrition: Terminology, Definitions and General topics

    Clin Nutr

    (2006)
  • A. Laviano et al.

    Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies

    Lancet Oncol

    (2003)
  • K. Kalantar-Zadeh et al.

    Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients

    Am J Clin Nutr

    (2004)
  • S. Black et al.

    C-reactive protein

    J Biol Chem

    (2004)
  • A. Schols et al.

    Body composition and mortality in chronic obstructive pulmonary disease

    Am J Clin Nutr

    (2005)
  • G. Goldspink

    Impairment of IGF-I gene splicing and MGF expression associated with muscle wasting

    Int J Biochem Cell Biol

    (2006)
  • A. Saini et al.

    Waste management – cytokines, growth factors and cachexia

    Cytokine Growth Factor Rev

    (2006)
  • D.R. Thomas

    Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia

    Clin Nutr

    (2007)
  • G. Biolo et al.

    Metabolic consequences of physical inactivity

    J Ren Nutr

    (2005)
  • C.M. Prado et al.

    Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study

    Lancet Oncol

    (2008)
  • G. Biolo et al.

    Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest

    Am J Clin Nutr

    (2008 Oct)
  • V.A. Hughes et al.

    Longitudinal changes in body composition in older men and women: role of body weight change and physical activity

    Am J Clin Nutr

    (2002)
  • J.E. Morley et al.

    Cachexia: pathophysiology and clinical relevance

    Am J Clin Nutr

    (2006)
  • M. Plauth et al.

    Cachexia in liver cirrhosis

    Int J Cardiol

    (2002)
  • M.J. Delano et al.

    The origins of cachexia in acute and chronic inflammatory diseases

    Nutr Clin Pract

    (2006)
  • R. Meier et al.

    Epidemiology of malnutrition

  • R.J. Stratton et al.

    Malnutrition in hospital outpatients and inpatients: prevalence, concurrent validity and easy of use of the “malnutrition universal screening tool” (MUST) for adults

    Br J Nutr

    (2004)
  • R.J. Stratton

    Should food or supplements be used in the community for the treatment of disease related malnutrition?

    Proc Nutr Soc

    (2005)
  • A. Laviano et al.

    Therapy insight: cancer anorexia-cachexia syndrome: when all you can eat is yourself

    Nat Clin Pract Oncol

    (2005)
  • R. Roubenoff

    Origins and clinical relevance of sarcopenia

    Can J Appl Physiol

    (2001)
  • I. Janssen et al.

    Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability

    J Am Geriatr Soc

    (2002)
  • W.J. Evans

    What is sarcopenia?

    J Gerontol A Biol Sci Med Sci

    (1995)
  • M. Pahor et al.

    Research hypotheses on muscle wasting, aging, loss of function and disability

    J Nutr Health Aging

    (1998)
  • R.N. Baumgartner et al.

    Epidemiology of sarcopenia among the elderly in New Mexico

    Am J Epidemiol

    (1998)
  • S.M. Schneider et al.

    Sarcopenia is prevalent in patients with Crohn's disease in clinical remission

    Inflamm Bowel Dis

    (2008)
  • Cited by (1275)

    • Assisted Enteral Feeding of Exotic Companion Animals

      2024, Veterinary Clinics of North America - Exotic Animal Practice
    View all citing articles on Scopus
    n

    SIG “cachexia-anorexia in chronic wasting diseases”.

    o

    SIG “nutrition in geriatrics”.

    View full text